May 18, 2026 · Form 4 insider transaction
Brady Kelly sold 59 shares of Seres Therapeutics, Inc. at $7.53 per share, a transaction worth $444.27. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 1 day after the transaction.
Represents shares sold to cover taxes in connection with the vesting of the restricted stock units.